In a cohort of patients with metastatic colorectal cancer, progression free survival was higher in patients with FcγRIIa-131H/H and FcγRIIIa-158V/V genotypes, regardless of the KRAS status15. The gene discussed is FCGR3A; the disease is metastatic colorectal cancer.